17. Veterans & Psychedelics part 3 – From Shock to Awe with Mitch Schultz

17. Veterans & Psychedelics part 3 – From Sho...

Up next

150. Synthetic Alcohol with David Orren

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial communication with David Nutt and emphasises their shared mission to speak to youn ...  Show more

149. Psilocybin for Cancer with Dr Lauren Macdonald

In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that left her with existential dread that she felt fully dissipate only after a psyched ...  Show more

Recommended Episodes

Can Psychedelic Therapy Reset Our Social Media Brains?
Your Undivided Attention

When you look at the world, it can feel like we're in a precarious moment. If you’ve listened to past episodes, you know we call this the meta-crisis — an era of overlapping and interconnected crises like climate change, polarization, and the rise of decentralized technologies li ...  Show more

086 | DMT: The Mystery of Psychedelics & What The Research Shows w/ Dr. Rick Strassman
Modern Psychedelics

Dr. Rick Strassman is gracing us with his wisdom today! He has appeared on the #1 global show, The Joe Rogan podcast, so it’s quite a treat for us to hear from him on this corner of the podcasting world.

Dr. Rick Strassman needs no introduction: he is the leading global ...

  Show more

Psychedelics
Overthink

No, you’re not hallucinating! In episode 89 of Overthink, Ellie and David investigate the loopy world of psychedelics. Did you know that after doing psychedelics Jean-Paul Sartre went through a  “lobster phase” during which he hallucinated lobsters everywhere he went? Once par ...

  Show more

#177 — Psychedelic Science
Making Sense with Sam Harris

Sam Harris speaks with Roland Griffiths about the current state of research on psychedelics. They discuss the historical prohibition against their use; the clinical and scientific promise of psilocybin, mescaline, LSD, DMT, MDMA, and other compounds; the risks associated with ...

  Show more